Manifest Technologies emerged from stealth with strategic investors and prepares for the next development stage of AI-powered precision neuroscience.

Mar 28, 2024•over 1 year ago

New HavenMachine LearningArtificial IntelligenceBiotechnologyHealth Care

Investors

Kaleida CapitalJohnson & JohnsonNih Funded Research At Yale

Description

Manifest Technologies unveiled the company after completing its initial funding and partnership with a top five global pharmaceutical company. The company aims to transform how CNS treatments are developed and delivered in the clinic, leveraging computational neuroscience and AI to enable a true precision medicine approach to mental illness and neurodegenerative diseases like Alzheimer’s Disease and Parkinson’s Disease.

Company Information

Company

Manifest Technologies

Location

New Haven, Kentucky, United States

About

Manifest Technologies is transforming CNS health through AI-powered precision neuroscience and computational neuroimaging. Manifest was founded in 2021 by a group of leading scientists who have created the NAIO™ (Neuroscience and Artificial Intelligence Optimized) platform. NAIO™ incorporates proprietary software and several patents under an exclusive license from Yale University. Manifest is building a suite of specific applications out of the NAIO™ platform to meet the needs of both pharmaceutical CNS R&D and health care providers.

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers